RecruitingNot ApplicableNCT06098469
Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression
Sponsor
Centre Hospitalier Universitaire de Besancon
Enrollment
22 participants
Start Date
Oct 10, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The study evaluate the effect of 10 neurofeedback sessions on the residual symptoms of depressive patients in partial remission.
Eligibility
Min Age: 25 YearsMax Age: 65 Years
Inclusion Criteria7
- Subjects aged 25 to 65 included
- Information and signed informed consent
- Patients with a diagnosis of major depressive episode in remission
- MADRS score between 14 and 22
- Patients with residual symptoms as assessed by MADRS items
- No cognitive impairment.
- Right-handed
Exclusion Criteria6
- Subjects with legal incapacity or limited legal capacity
- Subjects unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator
- Pregnant women
- Subjects in the exclusion period of another study or is on the "national volunteer list".
- Subjects with another psychiatric pathology (bipolar mood disorder, psychosis, obsessive-compulsive disorder, addictive pathology, schizophrenia)
- Subjects under a protective measure such as guardianship or safeguard of justice.
Interventions
DEVICENeurofeedback sessions
10 Neurofeedback sessions, psychiatric interview (MADRS, QIDS-C16), reverse-correlation task, QIDS-SR16, EQ-5D-5L, motivation assessment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06098469
Related Trials
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT0679339767 locations
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
NCT073648253 locations
Cerebellar Stimulation and Cognitive Control
NCT032171101 location
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
NCT036781941 location
The Effects of High-dose Vitamin B6 on Depression and Anxiety Symptoms
NCT074694621 location